After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking

5 trades

Disclosure transactions for Damora Therapeutics, Inc.
Reporting person Filed Transaction Transaction value Source Actions
Jarrett Jennifer Director, President And CEO Sep 28, 2026 3-day lag Buy Sep 25, 2026 $252.88K Filed shares x price SEC Form 4 View filing
Cheng Andrew Director Aug 13, 2026 1-day lag Award Aug 12, 2026 $0 Filed shares x price SEC Form 4 View filing
Winslow Garrett General Counsel Jul 7, 2026 1-day lag Sale Jul 6, 2026 $7.35K Filed shares x price SEC Form 4 View filing
Winslow Garrett General Counsel Jul 7, 2026 4-day lag Exercise Jul 3, 2026 Not reported Reported range SEC Form 4 View filing
Winslow Garrett General Counsel Jul 7, 2026 4-day lag Exercise Jul 3, 2026 $0 Filed shares x price SEC Form 4 View filing
Jarrett Jennifer Director, President And CEO
Buy
Calculated transaction value
$252.88K 12,500 shares @ $20.23
Traded
Sep 25, 2026
Filed
Sep 28, 2026
Cheng Andrew Director
Award
Calculated transaction value
$0 30,350 shares @ $0
Traded
Aug 12, 2026
Filed
Aug 13, 2026
Winslow Garrett General Counsel
Sale
Calculated transaction value
$7.35K 245 shares @ $29.98
Traded
Jul 6, 2026
Filed
Jul 7, 2026
Winslow Garrett General Counsel
Exercise
Reported value range
Not reported 680 shares
Traded
Jul 3, 2026
Filed
Jul 7, 2026
Winslow Garrett General Counsel
Exercise
Calculated transaction value
$0 680 shares @ $0
Traded
Jul 3, 2026
Filed
Jul 7, 2026